Form 8-K - Current report:
SEC Accession No. 0001808665-22-000059
Filing Date
2022-11-08
Accepted
2022-11-08 16:03:27
Documents
13
Period of Report
2022-09-30
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K asrt-20221108.htm   iXBRL 8-K 50284
2 EX-3.1 exhibit31q32022.htm EX-3.1 193637
  Complete submission text file 0001808665-22-000059.txt   426540

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asrt-20221108.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asrt-20221108_lab.xml EX-101.LAB 25950
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asrt-20221108_pre.xml EX-101.PRE 13685
7 EXTRACTED XBRL INSTANCE DOCUMENT asrt-20221108_htm.xml XML 11076
Mailing Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045
Business Address 100 S. SAUNDERS ROAD SUITE 300 LAKE FOREST IL 60045 (224) 419-7106
Assertio Holdings, Inc. (Filer) CIK: 0001808665 (see all company filings)

EIN.: 850598378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39294 | Film No.: 221368794
SIC: 2834 Pharmaceutical Preparations